Skip to main content
Smart Investors Daily
AI

NASDAQ · AIKI

AIkido Pharma Inc.

Healthcare · Biotechnology

$3.56

Up+$0.03 (+0.85%)

Updated Aug 13, 2026, 11:09 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
19.53M
P/E ratio
0.42
Dividend yield
0.00%
52-week range
— – —
Volume
31.93K
Avg. volume
38.13K

Price performance

AIKI price history

1M range · 0 trading sessions · Daily adjusted prices

AIKI does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest AIKI news

The latest Smart Investors Daily articles mentioning AIKI.

AIKI research

Overview

Company profile and research snapshot.

Company profile

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
AIKI recent ratings
DateFirmRatingTarget
Nov 11, 2022HC Wainwright & Co.Buy
Oct 11, 2021HC Wainwright & Co.Buy
Open full forecast

News briefing

No generated briefing is available yet.

PennyStocks · Oct 1, 2021

Top Penny Stocks to Watch As October Gets Off to a Bullish Start

October is getting off to a great start for penny stocks, here's three to watch The post Top Penny Stocks to Watch As October Gets Off to a Bullish Start appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Benzinga · Apr 28, 2021

2 Robinhood Medical Favorites Are Looking Healthy

The SPDR S&P 500 (NYSE: SPY) hit a new all-time high Wednesday morning amid a week where many of the biggest tech companies report earnings. A boom in big board names is often followed by a rotation. This rotation usually has a trickledown effect where mid-sized companies are next to get a boost followed by juniors and penny stocks. Aikido Pharma Inc (NASDAQ: AIKI) and Brickell Biotech Inc (NASDAQ: BBI) made their last highs after the end of the fourth-quarter earnings season in February, reaching $2.55 and $1.70, respectively. Aikido and Brickell are also two heavily traded penny stocks in the Robinhood community. See Also: Best Biotech Penny Stocks The Aikido Pharma Chart: Aikido’s stock is down almost 60% from its 10-month high it made on Feb. 16. It looks to have put in a bottom at the 80-cent mark and by Wednesday morning had rebounded 32% from that level to $1.03. Aikido is trading above both price history resistance and psychological resistance at $1. ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.